Xcout Intel
Atsena Therapeutics, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Atsena Therapeutics, Inc. among biotechnology companies — ranked by similarity to what Atsena Therapeutics, Inc. actually does, not by market-cap band.
Subscribe to see Atsena Therapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. is a clinical-stage gene therapy company headquartered in Durham, North Carolina, established in 2019. The firm focuses on developing novel gene therapies to treat debilitating inherited blinding diseases using proprietary vector delivery technologies. Its scientific pipeline aims to address areas of high unmet medical need in ophthalmology.
Atsena Therapeutics, Inc. at a glance
Atsena Therapeutics, Inc. is a biotechnology company headquartered in United States. Its most recent funding round raised $90M in March 2025. Xcout tracks 12 named people at Atsena Therapeutics, Inc., including Patrick Ritschel (Chief Executive Officer Atsena Therapeutics).
Atsena Therapeutics, Inc. leadership
- Patrick RitschelChief Executive Officer Atsena Therapeutics
- Joseph S. ZakrzewskiChair of the Board
- Patrick RitschelExecutive Officer
- Chris CarpenterDirector Sofinnova
- Christina IsacsonDirector
- Dr. Norbert RiedelDirector
6 more named people on record for Atsena Therapeutics, Inc., with roles, board committees and tenure — see the full roster →
Atsena Therapeutics, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $90M | — | |
| SEC Form D filing | $24.5M | — | |
| SEC Form D filing | $27.5M | — | |
| SEC Form D filing | $4.1M | — | |
| — | $4.1M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Atsena Therapeutics, Inc. competitors
Ranked by semantic similarity — how close each company is to Atsena Therapeutics, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Life Science
ReCode Therapeutics is a clinical-stage genetic medicines company headquartered in Menlo Park, California, and Durham, North Carolina. The company leverages proprietary delivery systems to power a new class of disease-modifying genetic therapies.
Similar biotechnology company
Beacon Therapeutics is a clinical-stage biotechnology company dedicated to saving and restoring sight for people living with rare and prevalent ocular diseases. The company works to deliver advanced retinal gene therapies to patients experiencing blindness.
Similar biotechnology company
Kriya Therapeutics, Inc. is a fully integrated biopharmaceutical company with operational footprints in Redwood City, California, and Research Triangle Park, North Carolina. The company develops novel gene therapies to address diverse diseases.
Similar biotechnology company
Ray Therapeutics, Inc. is a privately held optogenetic gene therapy company headquartered in Berkeley, California. The company focuses on reimagining vision through innovative genetic treatments and novel therapeutic solutions.
Similar biotechnology company
Coave Therapeutics is a clinical-stage biotechnology company headquartered in Paris, France. The company focuses on developing life-changing gene therapies targeting rare ocular and central nervous system diseases.
Biotech
Taysha Gene Therapies, Inc. is a biotech firm specializing in the creation and market introduction of gene therapies that utilize adeno-associated virus (AAV) vectors. Its core mission is to tackle inherited diseases affecting the central nervous system (CNS). The company's development pipeline features several key programs: TSHA-120 is aimed at giant axonal neuropathy; TSHA-102 is in development for Rett syndrome; TSHA-121 and TSHA-118 are both being advanced for CLN1 disease; TSHA-105 addresses SLC13A5 Deficiency; and TSHA-101 targets GM2 gangliosidosis. Furthermore, Taysha has forged a strategic alliance with The University of Texas Southwestern Medical Center to jointly advance and bring to market innovative gene therapy solutions. Founded in 2019, the company operates from its headquarters in Dallas, Texas.
Biotech
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Similar biotechnology company
Hubble Therapeutics is a patient-focused biotechnology company based in New Hampshire that advances gene therapy to treat LCA16, a rare form of childhood blindness.
Similar biotechnology company
AskBio is a clinical-stage gene therapy company that develops adeno-associated virus (AAV) gene therapies to treat genetic and complex disorders. The company focuses on advancing genetic medicine through its proprietary technology platforms, manufacturing processes, and clinical trials.
Similar biotechnology company
Eyevensys is a biotechnology company developing non-viral gene therapies for ophthalmic diseases. Its platform uses electro-transfection of the eye’s ciliary muscle to enable sustained local production of therapeutic proteins for retinal and other ocular conditions.
Similar biotechnology company
Averna Therapeutics is a biotechnology company developing genomic medicines utilizing RNA and lipid nanoparticle technologies. The company focuses on safe and efficient gene insertion and the treatment of rare genetic diseases through research and development teams located in Boston and Israel.
Biotech
GenSight Biologics is a clinical-stage biopharmaceutical company that develops gene therapies to treat neurodegenerative retinal diseases and central nervous system disorders. The company focuses on addressing conditions such as Leber Hereditary Optic Neuropathy (LHON), Retinitis Pigmentosa, and Geographic Atrophy using technologies like gene therapy, mitochondrial targeting sequences, and optogenetics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Atsena Therapeutics, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Atsena Therapeutics, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →